Skip to main content
Knowledge4Policy
Knowledge for policy

Knowledge Centre on Cancer

We foster scientific and technical coordination of EU activities on cancer, while expanding the EU’s capacities and systems for prevention, early detection, treatment and care.

  • Page | Last updated: 10 Oct 2024

Recent EC funded projects that started in July - September 2024

Cancer
Project titleAcronymStart dateEnd dateCoordinatorFunding 
Elucidating the role of macroH2A1.2 histone variant as a metabolic sensor in the epigenetic regulation of leukaemia cell fate ChroMet 01/08/202431/07/2026FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS (ES)Marie Skłodowska-Curie Actions (MSCA) 
Understanding and targeting cancer persister cells CancerPersisters01/08/202431/07/2029TEL AVIV UNIVERSITY (IL)European Research Council (ERC) 
Elucidating the role of RNA-binding proteins in Kaposi’s sarcoma-associated herpesvirus infected cells during latency-reactivation switches KSHV-RBPome01/08/202431/07/2026MEDIZINISCHE HOCHSCHULE HANNOVER (DE)Marie Skłodowska-Curie Actions (MSCA) 
Demystifying the impact of HIV-antiretroviral therapy on fertility and the epigenome of gametes and early embryos EpiHIVgametesembryos01/08/202431/07/2026MEDIZINISCHE UNIVERSITAET WIEN (AT)Marie Skłodowska-Curie Actions (MSCA) 
Stem cell riboregulation: a new layer to control self-renewal, differentiation and metabolism SCRIBE01/08/202431/07/2026EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE)Marie Skłodowska-Curie Actions (MSCA) 
Deciphering METAstasis of lung cancer to BRAIN and developing new therapeutic approaches via a human metastatic cascade platformMETA-BRAIN01/08/202431/07/2029SABANCI UNIVERSITESI (Türkiye)European Research Council (ERC) 
Ultra-sensitive Field-resolved Infrared Spectroscopy for Early Disease DetectionUFRISED01/08/202431/07/2026MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (DE)Marie Skłodowska-Curie Actions (MSCA) 
Dynamic mapping of epigenetic regulation during embryogenesis using in vitro stem cell model DyMERE15/08/202414/08/2026MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (DE)Marie Skłodowska-Curie Actions (MSCA) 
In-cell Redox Catalysis by Co(III) Metallodrugs as New Tools for Cancer Treatments Co-CaReD28/08/202427/08/2026FUNDACION IMDEA NANOCIENCIA (ES)Marie Skłodowska-Curie Actions (MSCA) 
Development of a lung METAstasis-on-a-CHIP model for osteosarcoma as a biomimetic testing platform for drug discovery and therapeutic innovation META-CHIP01/09/202431/08/2029UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (IE)ERC STARTING GRANTS 
Quantitative HYpoxia imaging for charged ParticlE Radiation treatment guidance: an improved strategy for Aggressive brain Cancers Treatment HYPERACT01/09/202431/08/2026FONDAZIONE CENTRO NAZIONALE DI ADROTERAPIA ONCOLOGICA (IT)Marie Skłodowska-Curie Actions (MSCA) 
Identification of novel targets to improve glioblastoma therapy INTIGT01/09/202431/08/2026INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR)Marie Skłodowska-Curie Actions (MSCA) 
The natural K, Fe, and Cu isotopic response to Pt-based chemotherapeutic drug resistance in ovarian cancer CROC01/09/202431/08/2026UNIVERSITEIT GENT (BE)Marie Skłodowska-Curie Actions (MSCA) 
Deciphering immune evasion mechanisms of metastatic cancer cells using CRISPRa-inducible reporters immunoMet01/09/202431/08/2026FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH (AT)Marie Skłodowska-Curie Actions (MSCA) 
Nutrient fluctuations and the integrative stress response as metabolic cell fate determinants in B cell lymphoma NutFLirsFA01/09/202431/08/2026FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III (ES)Marie Skłodowska-Curie Actions (MSCA) 
Improving cellular cancer immunotherapy using chemotactic metabolite receptors MetaboTract01/09/202431/08/2026LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE)Marie Skłodowska-Curie Actions (MSCA) 
Spatio-temporal dynamics of immune circuitry in glioblastoma: from single cells to comprehensive models of tumor niches STIC-GBM01/09/202431/08/2026WEIZMANN INSTITUTE OF SCIENCE (IL)Marie Skłodowska-Curie Actions (MSCA) 
Desmoplastic Small Round Cell Tumor on the spotlight: introducing CAR-T cell therapy DSRCT-CAR01/09/202431/08/2026UNIVERSIDADE DE COIMBRA (PT)ERA Fellowships 
Enabling the next generation in search of blood cancer cures CarrerasPathfinders01/09/202431/08/2029UNIVERSITY OF SHARJAH (AE)Marie Skłodowska-Curie Actions (MSCA) 
VITNK - deciphering vitamin A and D regulation of human NK cells for cellular immunotherapy VITNK01/09/202431/08/2026KAROLINSKA INSTITUTET (SE)Marie Skłodowska-Curie Actions (MSCA) 
Development of a fluorescence-based nanotool for early breast cancer diagnosis NanoNIR01/09/202431/08/2026UNIVERSITAET REGENSBURG (DE)Marie Skłodowska-Curie Actions (MSCA) 
Targeting R2TP/TTT/WAC/mTOR complex in ovarian cancer  WAC-mTOR-OC01/09/202431/08/2026FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III (ES)Marie Skłodowska-Curie Actions (MSCA) 
Lead adjuvant probe as a dual technological tool to advance next-generation vaccine developmentADJUPROBE01/09/202428/02/2026ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS (ES)European Research Council (ERC) 
Protein Phototermal Optomechanical Analyzer PROPHOTOM01/09/202431/08/2026TECHNISCHE UNIVERSITEIT DELFT (NL)Marie Skłodowska-Curie Actions (MSCA) 
In situ growth of thermoplasmonic nanoparticles in microfluidic platforms for modifying stem cell fate PLASMOSTEMFATE01/09/202431/08/2026ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE (ES)Marie Skłodowska-Curie Actions (MSCA) 
Connecting mitochondrial defects to reduced autophagy in metabolic liver diseases through FATP2 MITOTUA01/09/202431/08/2026FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) (ES)Marie Skłodowska-Curie Actions (MSCA) 
Natural Language Processing to learn the language of the Human Genome GROVER01/09/202431/08/2026TECHNISCHE UNIVERSITAET DRESDEN (DE)Marie Skłodowska-Curie Actions (MSCA) 
Implementation of a novel in vitro methodology to assess pulmonary toxicological response mechanisms to high aspect ratio and complex materials IMPACT01/09/202431/08/2026BUNDESINSTITUT FUER RISIKOBEWERTUNG (DE)Marie Skłodowska-Curie Actions (MSCA) 
Protein degraders for targeting galectin-8 PROTAG-801/09/202431/08/2026LUNDS UNIVERSITET (SE)Marie Skłodowska-Curie Actions (MSCA) 
Backscattering coherent Stokes Raman scattering (sCiSsoRS) for real-time cancer diagnosticssCiSsoRS01/09/202431/08/2029CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (FR)European Research Council (ERC) 
Synthetic Chimeric Antigen Receptors: Hijacking Nitrenium Ions for Targeting, Therapy and Safety of Next Generation T Cell TherapySynCAR-Ts01/09/202431/08/2029UNIVERSITEIT LEIDEN (NL)European Research Council (ERC) 
A combined photoelectrochemical and fluorescence imaging system for investigating nanoparticle-cell interactionsNANO-PEFIS02/09/202401/09/2026UNIVERSITY OF HAMBURG (DE)Marie Skłodowska-Curie Actions (MSCA) 
Empowering Personalized Therapeutics: Advancing 3D-Nano DLD Arrays and Raman Micro-Biochips for Precision Isolation, Segmentation, and Molecular Profiling of Exosomal Trop2 Biomarkers in TNBCExoDiagAI16/09/202415/09/2026LEIBNIZ-INSTITUT FUER PHOTONISCHE TECHNOLOGIEN E.V. (DE)Marie Skłodowska-Curie Actions (MSCA) 
Cancer tailored next generation cellular therapiesCATACLIS01/10/202420/09/2029LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE)European Research Council (ERC) 
Vascular Control of NASH ProgressionCONNASHION01/10/202430/09/2029UNIVERSITA VITA-SALUTE SAN RAFFAELE (IT)European Research Council (ERC)